Evidence map›Paper›PMID 20035514›Full record

ArticleAnnals of neurology2009

Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome.

Melissa B Ramocki, Sarika U Peters, Y Jane Tavyev, Feng Zhang, Claudia M B Carvalho, Christian P Schaaf, Ronald Richman, Ping Fang, Daniel G Glaze, James R Lupski and 1 more

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 165 papers.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02705677 completednot on this mapstarted 2017, after this paper: background citation

Biobanking of Rett Syndrome and Related Disorders Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2017 to 2021Enrolled752ConditionsRett Syndrome, MECP2 Duplication, CDKL5, FOXG1 Disorders
NCT02738281 completednot on this mapstarted 2015, after this paper: background citation

Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol

TypeobservationalSponsorUniversity of Alabama at BirminghamRan2015 to 2021Enrolled1,044ConditionsRett Syndrome, MECP2 Duplication dIsorder, CDKL5 Disorder, FOXG1 Syndrome
3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 300 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Reciprocal regulation of the HbioRxiv : the preprint server for biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Sensory experiences questionnaire unravels differences in sensory profiles between MECP2-related disorders.Autism research : official journal of the International Society for Autism Research · 2024
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Melissa B RamockiSection of Child Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Sarika U Peters
Y Jane Tavyev
Feng Zhang
Claudia M B Carvalho
Christian P Schaaf
Ronald Richman
Ping Fang
Daniel G Glaze
James R Lupski
Huda Y Zoghbi
Baylor College of Medicine · USHoward Hughes Medical Institute · USTexas Children's Hospital · US

Funding

ZOLENDRONIC ACID IN CHILDREN W/ SEVERE OSTEOGENESIS IMPERFECTAM01RR000188 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LOUIS, CHRYSTAL U · 1985 to 2011
$30.6M
MOLECULAR PATHOGENESIS STUDIES OF RETT SYNDROMER01NS057819 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ZOGHBI, HUDA Y · 2006 to 2025
$7.5M
Mutidisciplinary Training;Brain Disorders &DevelopmentT32NS043124 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SWANN, JOHN WILLIAM · 2002 to 2021
$4.6M
Pathophysiology of MECP2 Spectrum Disorders (Career Development Award Proposal)K08NS062711 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI RAMOCKI, MELISSA BETH · 2008 to 2012
$861k
SIGNALING &METABOLIC ROLES OF GLUCOSE IN SPERMK01RR000188 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI TRAVIS, ALEXANDER J · 2000 to 2004
$589k
NCRR NIH HHS K01 RR000188NCRR NIH HHS M01 RR000188NCRR NIH HHS RR000188NINDS NIH HHS 1K08NS062711-01NINDS NIH HHS 1R01 NS057819-01NINDS NIH HHS K08 NS062711NINDS NIH HHS L40 NS060540NINDS NIH HHS R01 NS057819NINDS NIH HHS T32 NS043124NINDS NIH HHS T32 NS43124
6 · The paper itself

Abstract

objectiveThere have been no objective assessments to determine whether boys with MECP2 duplication have autism or whether female carriers manifest phenotypes. This study characterizes the clinical and neuropsychiatric phenotypes of affected boys and carrier females.

methodsEight families (9 males and 9 females) with MECP2 duplication participated. A detailed history, physical examination, electroencephalogram, developmental evaluation, Autism Diagnostic Observation Schedule, and Autism Diagnostic Interview-Revised were performed for each boy. Carrier females completed the Symptom Checklist-90-R, Wechsler Abbreviated Scale of Intelligence, Broad Autism Phenotype Questionnaire, and detailed medical and mental health histories. Size and gene content of each duplication were determined by array comparative genome hybridization. X-chromosome inactivation patterns were analyzed using leukocyte DNA. MECP2 and IRAK1 RNA levels were quantified from lymphoblast cell lines, and western blots were performed to assess MeCP2 protein levels.

resultsAll of the boys demonstrated mental retardation and autism. Poor expressive language, gaze avoidance, repetitive behaviors, anxiety, and atypical socialization were prevalent. Female carriers had psychiatric symptoms, including generalized anxiety, depression, and compulsions that preceded the birth of their children. The majority exhibited features of the broad autism phenotype and had higher nonverbal compared to verbal reasoning skills.

interpretationAutism is a defining feature of the MECP2 duplication syndrome in boys. Females manifest phenotypes despite 100% skewing of X-inactivation and normal MECP2 RNA levels in peripheral blood. Analysis of the duplication size, MECP2 and IRAK1 RNA levels, and MeCP2 protein levels revealed that most of the traits in affected boys are likely due to the genomic region spanning of MECP2 and IRAK1. The phenotypes observed in carrier females may be secondary to tissue-specific dosage alterations and require further study. Ann Neurol 2009;66:771-782.

Indexed as

Gene DuplicationGenetic Predisposition to DiseaseAdolescentAutistic DisorderChildChild, PreschoolChromosomes, Human, XFamily HealthFemaleHumansIntellectual DisabilityInterleukin-1 Receptor-Associated KinasesMaleMethyl-CpG-Binding Protein 2Neuropsychological TestsRNA, MessengerInterleukin-1 Receptor-Associated KinasesIRAK1 protein, humanMECP2 protein, humanMethyl-CpG-Binding Protein 2RNA, Messenger

Identifiers

PMID20035514
PMCPMC2801873
OpenAlexW2106863904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.